Clinical Trials Logo

Bone Diseases, Metabolic clinical trials

View clinical trials related to Bone Diseases, Metabolic.

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06351176 Enrolling by invitation - Clinical trials for Diabetes Mellitus, Type 1

Impact of Glycemic Control on Skeletal Outcomes in Adults With Type 1 Diabetes

DenSiFy cohort
Start date: July 4, 2023
Phase:
Study type: Observational

Background : Type 1 diabetes (T1D) is associated with an increased risk of fractures. The mechanisms accounting for this bone fragility are not yet fully understood. As T1D is often diagnosed in childhood or early adulthood, the lower bone mineral density (BMD) and deteriorated bone microarchitecture observed in T1D may reflect changes in the bone that occurred before or at the time of peak bone mass achievement. There is a lack of high-quality prospective studies to determine whether adults with T1D continue to lose BMD or deteriorate bone quality compared with controls. Moreover, while chronic hyperglycemia is a risk factor for fracture in T1D, it is unknown if better glycemic control affects bone outcomes. This prospective multicenter cohort study aims: (1) To compare the changes in the following outcomes over 4 years in adults with T1D and controls without diabetes of similar age, sex and body-mass index distribution: BMD by dual-energy X-ray absorptiometry (DXA) at the femoral neck, hip, spine, and radius, trabecular bone score (TBS) by DXA, and serum biochemical markers of bone turnover (BTMs); (2) To evaluate whether long-term glycemic control or the presence of a microvascular complication are independent predictors of the changes in BMD and TBS in people with T1D.

NCT ID: NCT05207124 Enrolling by invitation - Cerebral Palsy Clinical Trials

Sarcopenia and Osteopenia in Individuals With Cerebral Palsy and Influences After Botulinum Neurotoxin Type A Injection

Start date: September 2, 2020
Phase:
Study type: Observational

Botulinum neurotoxin type A (BoNT-A) intervention to control the hypertonia of muscles is one of the evidence-based managements for children with spastic cerebral palsy. However, BoNT-A injection in animal models to induce weakness had revealed some detrimental effects on muscular and skeletal systems. There are some objectives of this research. The first aim is to establish the baseline data of deficiencies in bone condition and muscle mass for individuals with cerebral palsy. To confirm the influences of intramuscular administration of Botox on muscular and bony health in this population is the other aim.

NCT ID: NCT04972240 Enrolling by invitation - Clinical trials for Marginal Bone Loss and Loss of Osteointegration of Short Implant

Stability, Marginal Bone Loss and Occlusal Load Analysis of PEEK Abutment Supported on Short Implant

Start date: August 2021
Phase: N/A
Study type: Interventional

this study will be directed toward evaluating stability, marginal bone loss and occlusal load of posterior customized PEEK abutments on Ti-bases supported by short implant

NCT ID: NCT04752098 Enrolling by invitation - Osteopenia Clinical Trials

A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method

Start date: September 2, 2020
Phase: N/A
Study type: Interventional

The goal of this project is to develop a new noninvasive ultrasound based technique, called vibro-acoustic analysis (VAA), for evaluation of infant bone health with particular application in assessment of bone health in premature infants who are at risk for bone disease.

NCT ID: NCT04195841 Enrolling by invitation - Bone Loss Clinical Trials

Influence of Z Shaped and Conventional Sulcular Incisions on Healing and Interproximal Bone Loss in Implant Surgery

Start date: November 20, 2018
Phase: N/A
Study type: Interventional

The present study is a human, prospective, parallel, randomised controlled clinical trial conducted to check the interproximal bone loss of Z shaped incision over conventional sulcular H shaped incision.The trial is in accordance with the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010.

NCT ID: NCT02237534 Enrolling by invitation - Clinical trials for Renal Insufficiency, Chronic

Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia

LAVALIER
Start date: September 2014
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the effect of lanthanum carbonate and calcium carbonate on the progression of coronary calcification and vascular endothelial dysfunction.